Dyadic International (NASDAQ:DYAI) Issues Quarterly Earnings Results, Beats Expectations By $0.06 EPS

Dyadic International (NASDAQ:DYAI) issued its quarterly earnings data on Tuesday. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.06, Zacks reports. The business had revenue of $1.96 million for the quarter, compared to the consensus estimate of $1.05 million. Dyadic International had a negative net margin of 188.09% and a negative return on equity of 149.16%. During the same period in the previous year, the firm earned ($0.06) EPS.

Dyadic International Stock Up 1.8 %

Dyadic International stock opened at $1.14 on Friday. Dyadic International has a one year low of $0.93 and a one year high of $2.67. The business’s fifty day moving average is $1.13 and its 200 day moving average is $1.42. The company has a quick ratio of 5.39, a current ratio of 5.15 and a debt-to-equity ratio of 1.54.

Wall Street Analyst Weigh In

Separately, HC Wainwright reiterated a “buy” rating and issued a $6.00 price target on shares of Dyadic International in a research note on Thursday.

Dyadic International Company Profile

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.